Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Literature
1.
Trachtman H (2012) Biomarkers of therapeutic response in primary nephrotic syndrome. Pediatr Nephrol. DOI: 10.1007/s00467-012-2225-6
2.
Bennett MR, Piyaphanee N, Czech K, Mitsnefes M, Devarajan P (2012) NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome. Pediatr Nephrol 27:807–812PubMedCrossRef
3.
Trachtman H, Gauthier B, Frank R, Futterweit S, Goldstein A, Tomczak J (1996) Increased urinary nitrite excretion in children with minimal change nephrotic syndrome. J Pediatr 128:173–176PubMedCrossRef
4.
Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, Chugh SS (2011) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17:117–122PubMedCrossRef
Metadata
Title
Biomarkers of therapeutic response in primary nephrotic syndrome: response
Author
Michael R. Bennett
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 1/2013
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-012-2256-z

Other articles of this Issue 1/2013

Pediatric Nephrology 1/2013 Go to the issue

Original Article

Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease

Original Article

Assessment of adult formulas for glomerular filtration rate estimation in children

Review

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative

Educational Review

Cystinosis: the evolution of a treatable disease

Letter to the Editors

Biomarkers of therapeutic response in primary nephrotic syndrome

Review

Drug-related problem in children with chronic kidney disease